STEPHANIE HORROCKS: Open Payments
NPI 1821557414 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,267 in 132 payments from 46 companies in 2025. Trend: 2023 $2,700 · 2024 $3,261 · 2025 $3,267
Food & beverage: $3,069Education: $199
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $278 |
| Novartis Pharmaceuticals Corporation | 11 | $231 |
| Celgene Corporation | 14 | $214 |
| SEAGEN INC. | 2 | $199 |
| Janssen Biotech, Inc. | 5 | $173 |
| AstraZeneca Pharmaceuticals LP | 6 | $156 |
| Agios Pharmaceuticals, Inc. | 4 | $132 |
| Incyte Corporation | 5 | $123 |
| Regeneron Healthcare Solutions, Inc. | 5 | $122 |
| ABBVIE INC. | 5 | $115 |
Products named: REBLOZYL, PYRUKYND, LIBTAYO, ELREXFIO, SCEMBLIX, MONJUVI, PADCEV, CARVYKTI.
Industry payments across MD — which companies pay providers there.
